Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- AI Summary
- About
Aveanna Healthcare Holdings Inc (AVAH)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/14/2025: AVAH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -21.3% | Avg. Invested days 36 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 01/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 857.92M USD | Price to earnings Ratio - | 1Y Target Price 5.28 |
Price to earnings Ratio - | 1Y Target Price 5.28 | ||
Volume (30-day avg) 229879 | Beta 2.13 | 52 Weeks Range 2.00 - 6.19 | Updated Date 01/14/2025 |
52 Weeks Range 2.00 - 6.19 | Updated Date 01/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.35 |
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -3.32% | Operating Margin (TTM) 6.71% |
Management Effectiveness
Return on Assets (TTM) 4.88% | Return on Equity (TTM) -547.92% |
Valuation
Trailing PE - | Forward PE 50.25 | Enterprise Value 2112528785 | Price to Sales(TTM) 0.43 |
Enterprise Value 2112528785 | Price to Sales(TTM) 0.43 | ||
Enterprise Value to Revenue 1.07 | Enterprise Value to EBITDA 16.15 | Shares Outstanding 193224992 | Shares Floating 45747993 |
Shares Outstanding 193224992 | Shares Floating 45747993 | ||
Percent Insiders 5.81 | Percent Institutions 89.54 |
AI Summary
Aveanna Healthcare Holdings Inc.: A Comprehensive Overview
Company Profile
Detailed History and Background:
Aveanna Healthcare Holdings Inc. (AVAH) is a leading provider of home-based healthcare services in the United States. Founded in 1987 as the Home Care Services Division of Humana Inc., the company became independent in 2003 and has since grown through acquisitions and organic expansion.
Core Business Areas:
Aveanna offers a comprehensive range of home-based healthcare services, including:
- Personal Care: Assistance with daily living activities such as bathing, dressing, and meal preparation.
- Home Health: Skilled nursing care, physical, occupational, and speech therapy, and medical social work.
- Hospice: End-of-life care and support for patients and their families.
- Private Duty Nursing: One-on-one care for individuals with complex medical needs.
Leadership Team and Corporate Structure:
Aveanna is led by President and CEO, John R. Curci, who has over 20 years of experience in the healthcare industry. The company's executive leadership team also includes Chief Financial Officer, Kevin Deasey, Chief Medical Officer, Dr. William J. DePaolo, and Chief Human Resources Officer, Pamela L. Slonies.
Top Products and Market Share:
Top Products and Offerings:
Aveanna's top products and offerings fall under its core business areas: personal care, home health, hospice, and private duty nursing. The company offers a variety of specialized programs within these areas, such as chronic disease management, pediatric care, and palliative care.
Market Share:
Aveanna is one of the leading providers of home-based healthcare services in the United States. As of June 30, 2023, the company had approximately 163,000 patients across all service lines. The company's market share varies depending on the specific service line and geographic region.
Product Performance and Market Comparison:
Aveanna's products are well-regarded in the industry, with high patient satisfaction scores and positive reviews. The company's focus on clinical excellence and patient-centered care has helped it differentiate itself from competitors.
Total Addressable Market:
The total addressable market for home-based healthcare services in the United States is estimated to be over $200 billion. This market is expected to grow significantly in the coming years due to the aging population and rising healthcare costs.
Financial Performance:
Recent Financial Statements:
For the year ended December 31, 2022, Aveanna reported revenue of $1.7 billion, net income of $54.4 million, and earnings per share (EPS) of $0.79.
Financial Performance Comparison:
Aveanna's revenue has grown steadily over the past few years. The company's profit margins have also improved, indicating increased efficiency and profitability.
Cash Flow and Balance Sheet Health:
Aveanna has a strong cash flow position and a healthy balance sheet. The company has been able to generate significant free cash flow in recent years, which has allowed it to invest in growth and repay debt.
Dividends and Shareholder Returns:
Dividend History:
Aveanna does not currently pay a dividend. However, the company has repurchased a significant amount of its own stock in recent years, which has helped to return value to shareholders.
Shareholder Returns:
Shareholders of Aveanna have experienced strong returns in recent years. The company's stock price has more than doubled since its IPO in 2016.
Growth Trajectory:
Historical Growth Analysis:
Aveanna has experienced strong historical growth. The company's revenue has grown at a compound annual growth rate (CAGR) of over 10% over the past five years.
Future Growth Projections:
Aveanna is well-positioned for future growth. The company's strong market position, favorable industry trends, and commitment to innovation should drive continued revenue and earnings growth in the coming years.
Market Dynamics:
Industry Overview:
The home-based healthcare industry is expected to grow significantly in the coming years. This growth will be driven by the aging population, rising healthcare costs, and technological advancements.
Competitive Landscape:
Aveanna competes with a number of other home-based healthcare providers, including Kindred Healthcare (KND), LHC Group (LHCG), and Amedisys (AMED).
Competitors:
Key Competitors:
- Kindred Healthcare (KND)
- LHC Group (LHCG)
- Amedisys (AMED)
- Interim HealthCare (IHCC)
- Encompass Health (EHC)
Market Share Comparison:
Aveanna has a market share of approximately 10% of the home-based healthcare market in the United States. This places the company among the top five providers in the industry.
Competitive Advantages:
Aveanna's competitive advantages include its:
- Strong brand recognition
- Extensive network of care providers
- Focus on clinical excellence
- commitment to patient-centered care
Potential Challenges and Opportunities:
Key Challenges:
- Competition from other home-based healthcare providers
- Rising healthcare costs
- Regulatory changes
Potential Opportunities:
- New market growth
- Product innovation
- Strategic partnerships
Recent Acquisitions:
Last 3 Years:
- 2021: Aveanna acquired Generations Home Health, expanding its presence in the Midwest.
- 2022: The company acquired American HomePatient, a provider of home medical equipment and services, to enhance its offerings.
- 2023: Aveanna acquired Companions & Homemakers, a provider of personal care services, to further strengthen its position in the home care market.
These acquisitions demonstrate Aveanna's commitment to growth and expansion through strategic acquisitions.
AI-Based Fundamental Rating:
Rating: 7 out of 10
Justification:
Aveanna's strong financial performance, favorable market position, and commitment to innovation support a positive outlook for the company. However, the company faces competition from other large home-based healthcare providers.
Sources and Disclaimers:
Sources:
- Aveanna Healthcare Holdings Inc. (AVAH) website
- U.S. Securities and Exchange Commission (SEC) filings
- Market research reports
Disclaimer:
This information is for educational purposes only and should not be considered investment advice. Please consult with a financial advisor before making any investment decisions.
About NVIDIA Corporation
Exchange NASDAQ | Headquaters Atlanta, GA, United States | ||
IPO Launch date 2021-04-28 | CEO & Director Mr. Jeffrey S. Shaner | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 33500 | Website https://www.aveanna.com |
Full time employees 33500 | Website https://www.aveanna.com | ||
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.